German TAVI-Register

Sponsor
Stiftung Institut fuer Herzinfarktforschung (Other)
Overall Status
Completed
CT.gov ID
NCT02815514
Collaborator
(none)
3,000
1
95
31.6

Study Details

Study Description

Brief Summary

The TAVI - Register is a Germany-wide scientific elevation in which data about the aortic valve treatment and the therapeutic consequences are documented.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Documentation of all consecutive patients of the participating centers with significant aortic stenosis, undergoing one of the following therapies:

    1. Percutaneous transfemoral aortic valve replacement

    2. Percutaneous aortic valve replacement transapical

    3. Percutaneous aortic valve replacement transaortic

    4. Aortic valve balloon valvuloplasty

    5. Surgical aortic valve replacement

    6. Conservative treatment

    • Documentation of the indications, procedural results and clinical short-and long-term results of the above therapies

    • Documentation of operational risk and quality of life

    • Documentation of the technical implementation of the procedure and success of the intervention and of hospital reinterventions

    • Documentation of hospital mortality, nonfatal major complications (stroke, TIA, myocardial infarction, dialysis, vascular complications, bleeding, neuropsychological status)

    • Documentation of discharge medication and the length of hospital stay

    • Documentation of the serious long-term complications, including mortality, stroke, TIA, myocardial infarction, dialysis, the reintervention and quality of life and of drug therapy within 30 days, 1 year, 3 years and 5 years.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    3000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Deutsches TAVI-Register
    Study Start Date :
    Jan 1, 2009
    Actual Primary Completion Date :
    Nov 1, 2011
    Actual Study Completion Date :
    Dec 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Aortic valve procedures

    percutaneous transfemoral aortic valve implantation percutaneous transapical aortic valve implantation percutaneous transaortic aortic valve implantation aortic valve valvuloplasty surgical aortic valve replacement conservative treatment

    Outcome Measures

    Primary Outcome Measures

    1. All cause mortality [5 years]

    Secondary Outcome Measures

    1. Short- and long-term results of the documented therapies [5 years]

      Documentation of procedural results and clinical short-and long-term results of the documented therapies

    2. Details on operational risk [up to four weeks]

      Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.

    3. Details of performed procedures [up to four weeks]

      Documentation of the indications, the technical implementation of the procedures and success of the intervention and of possible hospital reinterventions. Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.

    4. Complications during hospital stay [up to four weeks]

      Documentation of hospital mortality, nonfatal major complications (stroke, TIA, myocardial infarction, dialysis, vascular complications, bleeding, neuropsychological status). Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.

    5. Details of hospital stay [up to four weeks]

      Documentation of e.g. drug treatment, discharge medication and the length of hospital stay. Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.

    6. Serious long-term complications [5 years]

      Documentation of the serious long-term complications, including mortality, stroke, TIA, myocardial infarction, dialysis and reinterventions

    7. Quality of life [5 years]

    8. Drug treatment [5 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    patients with aortic stenosis (degree III) who received one of the following therapies:

    • transapical operative aortic valve implantation

    • operative aortic valve implantation

    • percutaneous aortic valve implantation

    • balloon valvuloplasty

    Exclusion Criteria:
    • missing signed informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institut fur Herzinfarktforschung Ludwigshafen Ludwigshafen RPF Germany 67063

    Sponsors and Collaborators

    • Stiftung Institut fuer Herzinfarktforschung

    Investigators

    • Principal Investigator: Jochen Senges, MD, Stiftung Insitut fuer Herzinfarktforschung

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stiftung Institut fuer Herzinfarktforschung
    ClinicalTrials.gov Identifier:
    NCT02815514
    Other Study ID Numbers:
    • TAVI
    First Posted:
    Jun 28, 2016
    Last Update Posted:
    Apr 13, 2017
    Last Verified:
    Jun 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Stiftung Institut fuer Herzinfarktforschung
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 13, 2017